Kineticos Life Sciences Management

Inceptor Bio is a biotechnology company focused on developing innovative cell therapy solutions aimed at treating difficult-to-treat cancers. The company emphasizes novel mechanisms to enhance the performance of immune cells within the tumor microenvironment. By collaborating with university research programs, Inceptor Bio leverages its laboratory and manufacturing capabilities, along with the expertise of its cell and gene therapy specialists, to efficiently translate cutting-edge therapeutic approaches into clinical applications. Its platform is dedicated to identifying, incubating, and accelerating new technologies in cell and genetic therapy, ultimately striving to improve cancer treatment outcomes for patients.

Kinvard Bio is a biotech startup launched by Kineticos Life Sciences to combat antimicrobial resistance.

Clarametyx Biosciences, Inc. is a biotechnology company based in Columbus, Ohio, focused on developing targeted and immune-enabling biologic therapies to address persistent infections linked to biofilms. Founded in 2020, the company utilizes a novel technology platform designed to penetrate the protective layers surrounding bacteria, facilitating immune responses and enhancing the effectiveness of antibiotic interventions. Among its key developments is CMTX-001, a humanized monoclonal antibody currently in preclinical stages aimed at treating hospital-acquired pneumonia. Clarametyx's innovative approach seeks to combat life-threatening infections while addressing the growing concerns of antibiotic resistance.

Experic is a contract development and manufacturing organization (CDMO) that offers comprehensive pharmaceutical supply services throughout the entire product life cycle, from clinical trials to commercial production. The company specializes in various dosing and packaging formats, including capsule filling, powder and pellet dosing, and assembly of autoinjectors and pen devices. Experic utilizes advanced Harro Höfliger equipment within a state-of-the-art Class A GMP facility to ensure the highest quality standards, even for expedited projects. Its services encompass process development, analytical support, clinical trial supply, vendor management, packaging, and logistics, all delivered with a personalized approach to meet the specific needs of its clients.

Orthobond Corp. specializes in developing surface modification technologies that enhance the biological response of synthetic materials used in medical devices. Founded in 2003 and based in North Brunswick, New Jersey, the company offers a range of innovations, including self-assembled monolayers of phosphonate (SAMP) that promote osteoconductivity on inorganic implants without biologics. Additionally, Orthobond's bioresistant technology facilitates tissue integration into permanent implants, while its AI-SAMP anti-infective technology effectively prevents orthopedic infections by eliminating bacteria upon contact with the implant surface, thereby reducing the risk of biofilm formation both pre and post-operatively. These advancements aim to significantly decrease microbial contamination and enhance the safety and effectiveness of medical devices.

EnteroBiotix Limited is a biotechnology company based in Edinburgh, United Kingdom, founded in 2017. It specializes in researching, developing, and commercializing orally available products for fecal microbiota transplantation. The company creates microbiome-modulating drugs composed of bacterial communities derived from the human gastrointestinal tract, aimed at restoring health and preventing bacterial infections. EnteroBiotix focuses on addressing serious unmet medical needs by offering tailored high-diversity microbial therapeutics, which help physicians prevent and treat debilitating infections and diseases linked to imbalances in gut bacteria.

Kincell Bio specializes in the manufacturing of immune clinical cells to support the development of cell therapies. The company leverages its extensive scientific expertise and industry knowledge to provide efficient design, manufacturing, and analytical services for cell therapies. Through its advanced software tools and dedicated manufacturing facility, Kincell Bio facilitates a streamlined process for researchers and laboratories, helping them accelerate the development and delivery of cell therapies to patients. The company emphasizes transparency, accountability, and accuracy in its partnerships, making it a reliable ally for process and analytical development, as well as clinical cell therapy manufacturing services.

eXmoor Pharma is a consultancy focused on cell and gene therapies, as well as biopharmaceuticals. The company operates a contract development and manufacturing business that provides a variety of services tailored to the needs of its clients. These services include manufacturing strategy, process development consultancy, and bioprocess engineering. By leveraging its expertise, eXmoor Pharma helps organizations design and implement projects that align with their specific goals and commercial objectives in the rapidly evolving field of advanced therapy medicinal products (ATMPs).

Experic is a contract development and manufacturing organization (CDMO) that offers comprehensive pharmaceutical supply services throughout the entire product life cycle, from clinical trials to commercial production. The company specializes in various dosing and packaging formats, including capsule filling, powder and pellet dosing, and assembly of autoinjectors and pen devices. Experic utilizes advanced Harro Höfliger equipment within a state-of-the-art Class A GMP facility to ensure the highest quality standards, even for expedited projects. Its services encompass process development, analytical support, clinical trial supply, vendor management, packaging, and logistics, all delivered with a personalized approach to meet the specific needs of its clients.

Inceptor Bio is a biotechnology company focused on developing innovative cell therapy solutions aimed at treating difficult-to-treat cancers. The company emphasizes novel mechanisms to enhance the performance of immune cells within the tumor microenvironment. By collaborating with university research programs, Inceptor Bio leverages its laboratory and manufacturing capabilities, along with the expertise of its cell and gene therapy specialists, to efficiently translate cutting-edge therapeutic approaches into clinical applications. Its platform is dedicated to identifying, incubating, and accelerating new technologies in cell and genetic therapy, ultimately striving to improve cancer treatment outcomes for patients.

EnteroBiotix Limited is a biotechnology company based in Edinburgh, United Kingdom, founded in 2017. It specializes in researching, developing, and commercializing orally available products for fecal microbiota transplantation. The company creates microbiome-modulating drugs composed of bacterial communities derived from the human gastrointestinal tract, aimed at restoring health and preventing bacterial infections. EnteroBiotix focuses on addressing serious unmet medical needs by offering tailored high-diversity microbial therapeutics, which help physicians prevent and treat debilitating infections and diseases linked to imbalances in gut bacteria.

Kincell Bio specializes in the manufacturing of immune clinical cells to support the development of cell therapies. The company leverages its extensive scientific expertise and industry knowledge to provide efficient design, manufacturing, and analytical services for cell therapies. Through its advanced software tools and dedicated manufacturing facility, Kincell Bio facilitates a streamlined process for researchers and laboratories, helping them accelerate the development and delivery of cell therapies to patients. The company emphasizes transparency, accountability, and accuracy in its partnerships, making it a reliable ally for process and analytical development, as well as clinical cell therapy manufacturing services.